Clinical Trial

Vaccination with Autologous Dendritic Cells Loaded with Autologous Tumour Homogenate After Curative Resection for Stage IV Colorectal Cancer.

Study acronym: COREVAX-1
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Single-arm, monocentric trial to assess safety and immunological efficacy of adjuvant vaccination with autologous dendritic cells loaded with autologous tumour homogenate after curative resection for stage IV colorectal cancer
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2016-09-28; most recent amendment 2024-09-17.
Status change: Active, Not Recruiting → Recruiting 2020-04-20
Trial Details
NCT Number NCT02919644
Lead Sponsor Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Conditions Stage IV Colorectal Cancer, Curative Resection
Enrollment 19 participants
Start Date 2016-12-02
Primary Completion 2026-12 (estimated)
Study Completion 2031-12 (estimated)
Updated on ClinicalTrials.gov 2024-09-19